Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice

被引:23
作者
Candon, S
McHugh, RS
Foucras, G
Natarajan, K
Shevach, EM
Margulies, DH
机构
[1] NIAID, Mol Biol Sect, Immunol Lab, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] NIAID, Cellular Immunol Sect, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[3] NIAID, Immune Regulat Unit, Immunol Lab, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.172.5.2917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cells that lead to autoimmune gastritis (AIG) in BALB/c mice are either Th1 or Th2 cells. To test whether the phenotype of disease is related to the particular TCR expressed by the pathogenic cell, we have generated several lines of TCR transgenic mice using receptors cloned from pathogenic Th1 or Th2 cells. We previously described spontaneous inflammatory AIG in A23 mice, caused by the transgenic expression of the TCR from a Th1 clone, TXA23. In this study we describe the generation of A51 mouse-lines, transgenic for the TCR of a CD4(+) self-reactive Th2 clone, TXA51. A proportion of A51 mice spontaneously develop AIG by 10 wk of age, with a disease characterized by eosinophilic infiltration of the gastric mucosa and Th2 differentiation of transgenic T cells in the gastric lymph node. The Th2 phenotype of this autoimmune response seems to be related to a low availability of MHC class II-self peptide complexes. This in vivo model of spontaneous Th2-mediated, organ-specific autoimmunity provides a unique example in which the clonotypic TCR conveys the Th2 disease phenotype.
引用
收藏
页码:2917 / 2924
页数:8
相关论文
共 48 条
[1]  
Alderuccio F, 2000, HISTOL HISTOPATHOL, V15, P869, DOI 10.14670/HH-15.869
[2]   Tolerance and autoimmunity to a gastritogenic peptide in TCR transgenic mice [J].
Alderuccio, F ;
Cataldo, V ;
van Driel, IR ;
Gleeson, PA ;
Toh, BH .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (03) :343-352
[3]  
Arden Bernhard, 1995, Immunogenetics, V42, P501
[4]   Non-Th2 regulatory T-cell control of Th1 autoimmunity [J].
Bach, JF .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :21-29
[5]   Colitis in transgenic and knockout animals as models of human inflammatory bowel disease [J].
Bhan, AK ;
Mizoguchi, E ;
Smith, RN ;
Mizoguchi, A .
IMMUNOLOGICAL REVIEWS, 1999, 169 :195-207
[6]   Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 [J].
Boirivant, M ;
Fuss, IJ ;
Chu, A ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1929-1939
[7]   Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation [J].
Boonstra, A ;
Asselin-Paturel, C ;
Gilliet, M ;
Crain, C ;
Trinchieri, G ;
Liu, YJ ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) :101-109
[8]  
Coffman RL, 1999, CURR TOP MICROBIOL, V238, P1
[9]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[10]   Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens [J].
Elias, D ;
Meilin, A ;
Ablamunits, V ;
Birk, OS ;
Carmi, P ;
KonenWaisman, S ;
Cohen, IR .
DIABETES, 1997, 46 (05) :758-764